Both oral and intravenous ibandronate effectively prevent postmenopausal bone loss in women without osteoporosis. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • September 1, 2003